Table 1.

Comparison of 56 patients who had post-transplant histology suitable for inclusion in the study and 45 patients who did not

	Patients without histology	Patients with histology	p Value
n	45	56
Follow up (months)	12 (0–100)	42 (10–145)	<0.001
Death	16 (36%)	4 (7%)	<0.001
Death from liver failure	1	2	0.4
Age at transplant (y)	49 (33–65)	48 (28–67)	0.4
Males	35 (78%)	45 (80%)	0.7
Caucasian	27 (60%)	32 (57%)	0.8
Cyclosporin/tacrolimus	45/0	49/7	0.01
Treated rejection	16 (36%)	21 (37%)	0.8
More than 1 rejection episode	2	3	0.8
HBsAg positive	1	5	0.15
Cold ischaemic time (min)	709 (221–1140)	782 (201–1280)	0.4
Warm ischaemic time (min)	50 (33–79)	47 (25–76)	0.1
Donor age	45 (14–64)	42 (15–67)	0.6

Data are median (range) or number (%).

HBsAg, hepatitis B virus surface antigen.